Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 70 entries
Sorted by: Best Match Show Resources per page
Staging for prostate cancer.

JAMA

Brawer MK.
PMID: 8182820
JAMA. 1994 May 25;271(20):1628-9. doi: 10.1001/jama.271.20.1628a.

No abstract available.

Cite
Brawer MK. Staging for prostate cancer. JAMA. 1994;271(20):1628-9doi: 10.1001/jama.271.20.1628a.
Brawer, M. K. (1994). Staging for prostate cancer. JAMA, 271(20), 1628-9. https://doi.org/10.1001/jama.271.20.1628a
Brawer, M K. "Staging for prostate cancer." JAMA vol. 271,20 (1994): 1628-9. doi: https://doi.org/10.1001/jama.271.20.1628a
Brawer MK. Staging for prostate cancer. JAMA. 1994 May 25;271(20):1628-9. doi: 10.1001/jama.271.20.1628a. PMID: 8182820.
Copy Download .nbib Format: NLM
Epidemiology and Demographics of the Head and Neck Cancer Population.

Oral and maxillofacial surgery clinics of North America

Cohen N, Fedewa S, Chen AY.
PMID: 30078696
Oral Maxillofac Surg Clin North Am. 2018 Nov;30(4):381-395. doi: 10.1016/j.coms.2018.06.001. Epub 2018 Aug 03.

Head and neck malignancies comprise a heterogeneous group of malignancies that cause significant morbidity to those affected. These malignancies are associated with specific risk factors and exposures, some of which impact prognosis. The most common risk factors for developing...

Cite
Cohen N, Fedewa S, Chen AY. Epidemiology and Demographics of the Head and Neck Cancer Population. Oral Maxillofac Surg Clin North Am. 2018;30(4):381-395doi: 10.1016/j.coms.2018.06.001.
Cohen, N., Fedewa, S., & Chen, A. Y. (2018). Epidemiology and Demographics of the Head and Neck Cancer Population. Oral and maxillofacial surgery clinics of North America, 30(4), 381-395. https://doi.org/10.1016/j.coms.2018.06.001
Cohen, Natasha, et al. "Epidemiology and Demographics of the Head and Neck Cancer Population." Oral and maxillofacial surgery clinics of North America vol. 30,4 (2018): 381-395. doi: https://doi.org/10.1016/j.coms.2018.06.001
Cohen N, Fedewa S, Chen AY. Epidemiology and Demographics of the Head and Neck Cancer Population. Oral Maxillofac Surg Clin North Am. 2018 Nov;30(4):381-395. doi: 10.1016/j.coms.2018.06.001. Epub 2018 Aug 03. PMID: 30078696.
Copy Download .nbib Format: NLM
Towards precision oncology in advanced prostate cancer.

Nature reviews. Urology

Ku SY, Gleave ME, Beltran H.
PMID: 31591549
Nat Rev Urol. 2019 Nov;16(11):645-654. doi: 10.1038/s41585-019-0237-8. Epub 2019 Oct 07.

Metastatic biopsy programmes combined with advances in genomic sequencing have provided new insights into the molecular landscape of castration-resistant prostate cancer (CRPC), identifying actionable targets, and emerging resistance mechanisms. The detection of DNA repair aberrations, such as mutation of...

Cite
Ku SY, Gleave ME, Beltran H. Towards precision oncology in advanced prostate cancer. Nat Rev Urol. 2019;16(11):645-654doi: 10.1038/s41585-019-0237-8.
Ku, S. Y., Gleave, M. E., & Beltran, H. (2019). Towards precision oncology in advanced prostate cancer. Nature reviews. Urology, 16(11), 645-654. https://doi.org/10.1038/s41585-019-0237-8
Ku, Sheng-Yu, et al. "Towards precision oncology in advanced prostate cancer." Nature reviews. Urology vol. 16,11 (2019): 645-654. doi: https://doi.org/10.1038/s41585-019-0237-8
Ku SY, Gleave ME, Beltran H. Towards precision oncology in advanced prostate cancer. Nat Rev Urol. 2019 Nov;16(11):645-654. doi: 10.1038/s41585-019-0237-8. Epub 2019 Oct 07. PMID: 31591549; PMCID: PMC6858516.
Copy Download .nbib Format: NLM
Genetic clues can be used to predict whether early-stage cancer will form an invasive tumour.

Nature

Greulich H, Cherniack AD.
PMID: 30778180
Nature. 2019 Feb;566(7744):336-337. doi: 10.1038/d41586-019-00567-2.

No abstract available.

Cite
Greulich H, Cherniack AD. Genetic clues can be used to predict whether early-stage cancer will form an invasive tumour. Nature. 2019;566(7744):336-337doi: 10.1038/d41586-019-00567-2.
Greulich, H., & Cherniack, A. D. (2019). Genetic clues can be used to predict whether early-stage cancer will form an invasive tumour. Nature, 566(7744), 336-337. https://doi.org/10.1038/d41586-019-00567-2
Greulich, Heidi, and Cherniack, Andrew D. "Genetic clues can be used to predict whether early-stage cancer will form an invasive tumour." Nature vol. 566,7744 (2019): 336-337. doi: https://doi.org/10.1038/d41586-019-00567-2
Greulich H, Cherniack AD. Genetic clues can be used to predict whether early-stage cancer will form an invasive tumour. Nature. 2019 Feb;566(7744):336-337. doi: 10.1038/d41586-019-00567-2. PMID: 30778180.
Copy Download .nbib Format: NLM
Histogenetic Guidelines to Perform Sentinel Lymph Node Biopsy in T1b Melanomas of the 8th Edition American Joint Committee on Cancer.

Journal of the American College of Surgeons

Roncati L, Piscioli F.
PMID: 31431280
J Am Coll Surg. 2019 Sep;229(3):324-325. doi: 10.1016/j.jamcollsurg.2019.04.021.

No abstract available.

Cite
Roncati L, Piscioli F. Histogenetic Guidelines to Perform Sentinel Lymph Node Biopsy in T1b Melanomas of the 8th Edition American Joint Committee on Cancer. J Am Coll Surg. 2019;229(3):324-325doi: 10.1016/j.jamcollsurg.2019.04.021.
Roncati, L., & Piscioli, F. (2019). Histogenetic Guidelines to Perform Sentinel Lymph Node Biopsy in T1b Melanomas of the 8th Edition American Joint Committee on Cancer. Journal of the American College of Surgeons, 229(3), 324-325. https://doi.org/10.1016/j.jamcollsurg.2019.04.021
Roncati, Luca, and Piscioli, Francesco. "Histogenetic Guidelines to Perform Sentinel Lymph Node Biopsy in T1b Melanomas of the 8th Edition American Joint Committee on Cancer." Journal of the American College of Surgeons vol. 229,3 (2019): 324-325. doi: https://doi.org/10.1016/j.jamcollsurg.2019.04.021
Roncati L, Piscioli F. Histogenetic Guidelines to Perform Sentinel Lymph Node Biopsy in T1b Melanomas of the 8th Edition American Joint Committee on Cancer. J Am Coll Surg. 2019 Sep;229(3):324-325. doi: 10.1016/j.jamcollsurg.2019.04.021. PMID: 31431280.
Copy Download .nbib Format: NLM
Lung cancer staging: pathology issues.

Seminars in diagnostic pathology

Sica GL, Gal AA.
PMID: 23062419
Semin Diagn Pathol. 2012 Aug;29(3):116-26. doi: 10.1053/j.semdp.2012.06.001.

The previous, 6th, American Joint Committee on Cancer and International Union Against Cancer Staging Manual classification of lung cancer was largely unchanged from 5th edition. However, the most recent, 7th, edition has significantly updated the tumor, node, metastasis classification...

Cite
Sica GL, Gal AA. Lung cancer staging: pathology issues. Semin Diagn Pathol. 2012;29(3):116-26doi: 10.1053/j.semdp.2012.06.001.
Sica, G. L., & Gal, A. A. (2012). Lung cancer staging: pathology issues. Seminars in diagnostic pathology, 29(3), 116-26. https://doi.org/10.1053/j.semdp.2012.06.001
Sica, Gabriel L, and Gal, Anthony A. "Lung cancer staging: pathology issues." Seminars in diagnostic pathology vol. 29,3 (2012): 116-26. doi: https://doi.org/10.1053/j.semdp.2012.06.001
Sica GL, Gal AA. Lung cancer staging: pathology issues. Semin Diagn Pathol. 2012 Aug;29(3):116-26. doi: 10.1053/j.semdp.2012.06.001. PMID: 23062419.
Copy Download .nbib Format: NLM
"A systematic analysis highlighting deficiencies in reported outcomes for patients with stage IV colorectal cancer undergoing palliative resection of the primary tumor" by DP Harji et al.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Sterpetti AV.
PMID: 30343995
Eur J Surg Oncol. 2019 Feb;45(2):296-297. doi: 10.1016/j.ejso.2018.09.025. Epub 2018 Oct 11.

No abstract available.

Cite
Sterpetti AV. "A systematic analysis highlighting deficiencies in reported outcomes for patients with stage IV colorectal cancer undergoing palliative resection of the primary tumor" by DP Harji et al. Eur J Surg Oncol. 2018;45(2):296-297doi: 10.1016/j.ejso.2018.09.025.
Sterpetti, A. V. (2019). "A systematic analysis highlighting deficiencies in reported outcomes for patients with stage IV colorectal cancer undergoing palliative resection of the primary tumor" by DP Harji et al. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 45(2), 296-297. https://doi.org/10.1016/j.ejso.2018.09.025
Sterpetti, Antonio V. ""A systematic analysis highlighting deficiencies in reported outcomes for patients with stage IV colorectal cancer undergoing palliative resection of the primary tumor" by DP Harji et al." European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology vol. 45,2 (2019): 296-297. doi: https://doi.org/10.1016/j.ejso.2018.09.025
Sterpetti AV. "A systematic analysis highlighting deficiencies in reported outcomes for patients with stage IV colorectal cancer undergoing palliative resection of the primary tumor" by DP Harji et al. Eur J Surg Oncol. 2019 Feb;45(2):296-297. doi: 10.1016/j.ejso.2018.09.025. Epub 2018 Oct 11. PMID: 30343995.
Copy Download .nbib Format: NLM
Melanoma Staging: American Joint Committee on Cancer (AJCC) 8th Edition and Beyond.

Annals of surgical oncology

Gershenwald JE, Scolyer RA.
PMID: 29850954
Ann Surg Oncol. 2018 Aug;25(8):2105-2110. doi: 10.1245/s10434-018-6513-7. Epub 2018 May 30.

No abstract available.

Cite
Gershenwald JE, Scolyer RA. Melanoma Staging: American Joint Committee on Cancer (AJCC) 8th Edition and Beyond. Ann Surg Oncol. 2018;25(8):2105-2110doi: 10.1245/s10434-018-6513-7.
Gershenwald, J. E., & Scolyer, R. A. (2018). Melanoma Staging: American Joint Committee on Cancer (AJCC) 8th Edition and Beyond. Annals of surgical oncology, 25(8), 2105-2110. https://doi.org/10.1245/s10434-018-6513-7
Gershenwald, Jeffrey E, and Scolyer, Richard A. "Melanoma Staging: American Joint Committee on Cancer (AJCC) 8th Edition and Beyond." Annals of surgical oncology vol. 25,8 (2018): 2105-2110. doi: https://doi.org/10.1245/s10434-018-6513-7
Gershenwald JE, Scolyer RA. Melanoma Staging: American Joint Committee on Cancer (AJCC) 8th Edition and Beyond. Ann Surg Oncol. 2018 Aug;25(8):2105-2110. doi: 10.1245/s10434-018-6513-7. Epub 2018 May 30. PMID: 29850954.
Copy Download .nbib Format: NLM
PET/MRI Versus PET/CT for Whole-Body Staging: Results from a Single-Center Observational Study on 1,003 Sequential Examinations.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Martin O, Schaarschmidt BM, Kirchner J, Suntharalingam S, Grueneisen J, Demircioglu A, Heusch P, Quick HH, Forsting M, Antoch G, Herrmann K, Umutlu L.
PMID: 31806777
J Nucl Med. 2020 Aug;61(8):1131-1136. doi: 10.2967/jnumed.119.233940. Epub 2019 Dec 05.

Our purpose was to investigate differences between PET/MRI and PET/CT in lesion detection and classification in oncologic whole-body examinations and to investigate radiation exposure differences between the 2 modalities.

Cite
Martin O, Schaarschmidt BM, Kirchner J, et al. PET/MRI Versus PET/CT for Whole-Body Staging: Results from a Single-Center Observational Study on 1,003 Sequential Examinations. J Nucl Med. 2019;61(8):1131-1136doi: 10.2967/jnumed.119.233940.
Martin, O., Schaarschmidt, B. M., Kirchner, J., Suntharalingam, S., Grueneisen, J., Demircioglu, A., Heusch, P., Quick, H. H., Forsting, M., Antoch, G., Herrmann, K., & Umutlu, L. (2020). PET/MRI Versus PET/CT for Whole-Body Staging: Results from a Single-Center Observational Study on 1,003 Sequential Examinations. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 61(8), 1131-1136. https://doi.org/10.2967/jnumed.119.233940
Martin, Ole, et al. "PET/MRI Versus PET/CT for Whole-Body Staging: Results from a Single-Center Observational Study on 1,003 Sequential Examinations." Journal of nuclear medicine : official publication, Society of Nuclear Medicine vol. 61,8 (2020): 1131-1136. doi: https://doi.org/10.2967/jnumed.119.233940
Martin O, Schaarschmidt BM, Kirchner J, Suntharalingam S, Grueneisen J, Demircioglu A, Heusch P, Quick HH, Forsting M, Antoch G, Herrmann K, Umutlu L. PET/MRI Versus PET/CT for Whole-Body Staging: Results from a Single-Center Observational Study on 1,003 Sequential Examinations. J Nucl Med. 2020 Aug;61(8):1131-1136. doi: 10.2967/jnumed.119.233940. Epub 2019 Dec 05. PMID: 31806777.
Copy Download .nbib Format: NLM
Efficacy and safety of immune checkpoint inhibitors (ICIs) in extensive-stage small cell lung cancer (SCLC).

Journal of cancer research and clinical oncology

Ma X, Wang S, Zhang Y, Wei H, Yu J.
PMID: 32852633
J Cancer Res Clin Oncol. 2021 Feb;147(2):593-606. doi: 10.1007/s00432-020-03362-z. Epub 2020 Aug 27.

BACKGROUND: To evaluate the efficacy and safety of an immune checkpoint inhibitor (ICI) combined with chemotherapy in patients with advanced SCLC.METHODS: We searched published randomized-controlled trials (RCTs) to compare the effect of ICIs combined with chemotherapy and chemotherapy alone...

Cite
Ma X, Wang S, Zhang Y, et al. Efficacy and safety of immune checkpoint inhibitors (ICIs) in extensive-stage small cell lung cancer (SCLC). J Cancer Res Clin Oncol. 2020;147(2):593-606doi: 10.1007/s00432-020-03362-z.
Ma, X., Wang, S., Zhang, Y., Wei, H., & Yu, J. (2021). Efficacy and safety of immune checkpoint inhibitors (ICIs) in extensive-stage small cell lung cancer (SCLC). Journal of cancer research and clinical oncology, 147(2), 593-606. https://doi.org/10.1007/s00432-020-03362-z
Ma, Xiaoting, et al. "Efficacy and safety of immune checkpoint inhibitors (ICIs) in extensive-stage small cell lung cancer (SCLC)." Journal of cancer research and clinical oncology vol. 147,2 (2021): 593-606. doi: https://doi.org/10.1007/s00432-020-03362-z
Ma X, Wang S, Zhang Y, Wei H, Yu J. Efficacy and safety of immune checkpoint inhibitors (ICIs) in extensive-stage small cell lung cancer (SCLC). J Cancer Res Clin Oncol. 2021 Feb;147(2):593-606. doi: 10.1007/s00432-020-03362-z. Epub 2020 Aug 27. PMID: 32852633.
Copy Download .nbib Format: NLM
Current status of laparoscopic surgery for colorectal cancer based on the evidence of JCOG0404 trial.

Nihon rinsho. Japanese journal of clinical medicine

Inomata M, Akagi T, Nakajima K.
PMID: 30550702
Nihon Rinsho. 2016 Nov;74(11):1903-1908.

The concept of optimal surgery for colorectal cancer in Japan includes D3 dissection, which preserves the mesocolic plane by sharp dissection off the parietal plane, with central vascular ligation. In recent 25 years, laparoscopic surgery for colorectal cancers has...

Cite
Inomata M, Akagi T, Nakajima K. Current status of laparoscopic surgery for colorectal cancer based on the evidence of JCOG0404 trial. Nihon Rinsho. 2016;74(11):1903-1908
Inomata, M., Akagi, T., & Nakajima, K. (2016). Current status of laparoscopic surgery for colorectal cancer based on the evidence of JCOG0404 trial. Nihon rinsho. Japanese journal of clinical medicine, 74(11), 1903-1908.
Inomata, Masafumi, et al. "Current status of laparoscopic surgery for colorectal cancer based on the evidence of JCOG0404 trial." Nihon rinsho. Japanese journal of clinical medicine vol. 74,11 (2016): 1903-1908.
Inomata M, Akagi T, Nakajima K. Current status of laparoscopic surgery for colorectal cancer based on the evidence of JCOG0404 trial. Nihon Rinsho. 2016 Nov;74(11):1903-1908. Japanese. PMID: 30550702.
Copy Download .nbib Format: NLM
Identification of potential crucial genes associated with the pathogenesis and prognosis of prostate cancer.

Biomarkers in medicine

Mu HQ, Liang ZQ, Xie QP, Han W, Yang S, Wang SB, Zhao C, Cao YM, He YH, Chen J.
PMID: 32253914
Biomark Med. 2020 Apr;14(5):353-369. doi: 10.2217/bmm-2019-0318. Epub 2020 Apr 07.

No abstract available.

Cite
Mu HQ, Liang ZQ, Xie QP, et al. Identification of potential crucial genes associated with the pathogenesis and prognosis of prostate cancer. Biomark Med. 2020;14(5):353-369doi: 10.2217/bmm-2019-0318.
Mu, H. Q., Liang, Z. Q., Xie, Q. P., Han, W., Yang, S., Wang, S. B., Zhao, C., Cao, Y. M., He, Y. H., & Chen, J. (2020). Identification of potential crucial genes associated with the pathogenesis and prognosis of prostate cancer. Biomarkers in medicine, 14(5), 353-369. https://doi.org/10.2217/bmm-2019-0318
Mu, Hai-Qi, et al. "Identification of potential crucial genes associated with the pathogenesis and prognosis of prostate cancer." Biomarkers in medicine vol. 14,5 (2020): 353-369. doi: https://doi.org/10.2217/bmm-2019-0318
Mu HQ, Liang ZQ, Xie QP, Han W, Yang S, Wang SB, Zhao C, Cao YM, He YH, Chen J. Identification of potential crucial genes associated with the pathogenesis and prognosis of prostate cancer. Biomark Med. 2020 Apr;14(5):353-369. doi: 10.2217/bmm-2019-0318. Epub 2020 Apr 07. PMID: 32253914.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 70 entries